Home › Focal Segmental Glomerulosclerosis › Illinois › Chicago
Focal Segmental Glomerulosclerosis clinical trials in Chicago, IL
4 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Northwestern Memorial Hospital- Site Number : 8400014, Chicago
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
- Northwestern University, Chicago
NEPTUNE Match Study
Recruiting
- John H. Stroger, Jr., Hospital of Cook County, Chicago
Nephrotic Syndrome Study Network
RecruitingObservational study
- John Stroger Cook County Hospital, Chicago
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Miami, FL6 studies
- Queens, NY6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Cleveland, OH4 studies
- Kansas City, MO4 studies
- Dallas, TX4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)53 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity42 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.